Office of Diversion Control, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

February

Johnson Matthey, Inc. (February 19, 2015)

Navinta LLC (February 19, 2015)

Johnson Matthey, Inc. (February 19, 2015)

Mylan Technologies, Inc. (February 19, 2015)

United States Pharmacopeial Convention (February 19, 2015)

Research Triangle Institute (February 19, 2015)

Myoderm (February 11, 2015)

GE Healthcare (February 11, 2015)

Mallinckrodt LLC (February 11, 2015)

Siegfried USA, LLC (February 11, 2015)

Cambridge Isotope Lab (February 11, 2015)

Insys Therapeutics, Inc. (February 11, 2015)

American Radiolabeled Chemicals, Inc. (February 5, 2015)

Chattem Chemicals, Inc. (February 5, 2015)

Cerilliant Corporation (February 5, 2015)


January 2015

Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (January 30, 2015)

60-Day Notice: Application for Registration Renewal, Affidavit for Chain Renewal (DEA Forms 225, 225a and 225b) (January 30, 2015)

60-Day Notice: Application for Registration and Application for Registration Renewal (DEA Forms 363 and 363a) (January 30, 2015)

Mallinckrodt LLC (January 28, 2015)

Cambrex Charles City (January 28, 2015)

Research Triangle Institute (January 28, 2015)

Rhodes Technologies (January 28, 2015)

Johnson Matthey, Inc. (January 28, 2015)

Euticals, Inc. (January 26, 2015)

Halo Pharmaceutical, Inc. (January 26, 2015)

Fisher Clinical Services, Inc. (January 26, 2015)

Mylan Pharmaceuticals, Inc. (January 26, 2015)

Noramco, Inc. (January 26, 2015)

Cody Laboratories, Inc. (January 26, 2015)

Catalent CTS, LLC (January 26, 2015)

IRIX Manufacturing, Inc. (January 26, 2015)

Siemens Healthcare Diagnostics, Inc. (January 26, 2015)

Pharmacore, Inc. (January 26, 2015)

Lin Zhi International, Inc. (January 26, 2015)

Euticals, Inc. (January 26, 2015)

Stepan Company (January 26, 2015)

Ampac Fine Chemicals, LLC (January 26, 2015)

Chemtos, LLC (January 26, 2015)

Mallinckrodt, LLC (January 26, 2015)

Chattem Chemicals, Inc. (January 26, 2015)

Wildlife Laboratories, Inc. (January 26, 2015)

Cerilliant Corporation (January 26, 2015)

Apertus Pharmaceuticals (January 26, 2015)

Boehringer Ingelheim Chemical, Inc. (January 26, 2015)

S & B Pharma, Inc. (January 26, 2015)

Research Triangle Institute (January 26, 2015)

Noramco, Inc. (January 26, 2015)

Jose Raul S. Villavicencio, M.D.; Decision and Order (January 23, 2015)

Samuel Mintlow, M.D.; Decision and Order (January 23, 2015)

Removal of Naloxegol From Control (January 23, 2015)

Letter to Registrants: Final Rule Placed Hydrocodone Combinations (HCPs) into Schedule II, effective October 6, 2014 (PDF) (December 2, 2014)


December 2014

Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (December 19, 2014)

Electronic Prescriptions for Controlled Substances: Notice of Approved Certification Process (December 12, 2014)

Johnson Matthey Pharmaceutical Materials, Inc. (December 11, 2014)

Sigma Aldrich Research Biochemicals, Inc. (December 11, 2014)


November

Exemption From Registration for Persons Authorized Under U.S. Nuclear Regulatory Commission or Agreement State Medical Use Licenses or Permits and Administering the Drug Product DaTscan™ (November 25, 2014)

Webinar for Community Agencies: The DEA's Final Rule on Disposal of Controlled Substances

Richard D. Vitalis, D.O.; Decision and Order (November 18, 2014)

Martin L. Korn, M.D.; Decision and Order (November 7, 2014)

Alltech Associates, Inc. (November 7, 2014)

 


October

Removal of Naloxegol From Control (October 29, 2014)

Michael A. White, M.D.; Decision and Order (October 21, 2014)

Letter to Registrants seeks to clarify the DEA position regarding a practitioner’s disposal of pharmaceutical wastage (October 17, 2014)

Fiaz Afzal, M.D.; Decision And Order (October 14, 2014)

Fisher Clinical Services, Inc. (October 8, 2014)

Alkermes Gainesville LLC (October 8, 2014)

Austin Pharma, LLC (October 8, 2014)

Siemens Healthcare Diagnostics, Inc. (October 8, 2014)

Johnson Matthey, Inc. (October 7, 2014)

Noramco, Inc. (October 7, 2014)

Cerilliant Corporation (October 7, 2014)

R & D Systems, Inc. (October 7, 2014)

Chattem Chemicals, Inc. (October 7, 2014)

Meda Pharmaceuticals, Inc. (October 7, 2014)

Alltech Associates, Inc. (October 7, 2014)

The Medicine Shoppe; Decision and Order (October 2, 2014)


September

30-day Notice: U.S. Official Order Forms—Schedules I & II (DEA Form 222) (September 19, 2014)

Chattem Chemicals, Inc.; Correction (September 11, 2014)

Disposal of Controlled Substances; Final Rule (PDF) (September 9, 2014)

Drug Disposal Fact Sheets

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015 (September 8, 2014)

Fisher Clinical Services, Inc. (September 4, 2014)

Cody Laboratories, Inc. (September 4, 2014)

Mylan Technologies, Inc. (September 4, 2014)

Arizona Department of Corrections, ASPC-Florence (September 4, 2014)

Wildlife Laboratories, Inc. (September 4, 2014)

Akorn, Inc. (September 4, 2014)

Chattem Chemicals, Inc. (September 4, 2014)

Organix, Inc. (September 4, 2014)

National Center for Natural Products Research (NIDA MProject), Inc. (September 4, 2014)

Emergency Disaster Relief
Got Drugs? Turn in your unused or expired medication for safe disposal here.
Alert! Extortion Scam

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Office of Diversion Control  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539